FDA says 23 deaths linked to unapproved drug.WASHINGTON (Reuters) Feb 6, 2008. U.S. regulators said on Wednesday they would crack down on marketing of an unapproved injectable anti-gout drug which has been linked to 23 deaths.The Food and Drug Administration said injected forms of the drug, colchicine, can be highly toxic, and may lead to organ failure and death in excessive doses.[ See ]. Image from it.wikipedia. Watch video about FDA Drug Safety Newsletter now Available  in Read more.

FDA is announcing a new quarterly publication for healthcare professionals called the Drug Safety Newsletter. Every year, FDA receives more than 400,000 reports of adverse events associated with the use of drugs marketed in the U.S. FDA continually reviews these reports to identify signals of potential drug risks. The new Drug Safety Newsletter is designed to keep the medical community – including physicians, dentists, nurses and pharmacists – up to date on important safety findings derived from these reports and other sources of information. We hope the Drug Safety Newsletter helps you in making decisions about the drugs you use in your practice, and that it encourages you to report adverse events. You can get the newsletter and subscribe, free of charge, by going to the link below.FDA Patient Safety News: December 2007.For more information, please see our website:
http://www.accessdata.fda.gov/scripts